Deciphering the molecular mechanisms of epitranscriptome regulation in cancer

키워드

참고문헌 (100)

1. Zhou S, "Emergence of the noncoding cancer genome : a target of genetic and epigenetic alterations", Cancer Discovery, 6, pp.1215~1229 (2016)
2. Chiba T, "Inflamma-tion-associated cancer development in digestive organs : mechanisms and roles for genetic and epigenetic mo-dulation", Gastroenterology, 143, pp.550~563 (2012)
3. Kaiyuan Yu, "HIF1α promotes prostate cancer progression by increasing ATG5 expression", Animal Cells and Systems, 23(5), pp.326~334 (2019), 한국통합생물학회[DOI]
4. Heard E, "Transgenerational epigenetic inheritance : myths and mechanisms", Cell, 157, pp.95~109 (2014)
5. Zhao Y, "m1A regulated genes modulate PI3K", AKT, Transl Oncol, pp.2019, 12[DOI]
6. Tian QH, "METTL1overexpression is correlated with poor prognosis and promotes hepatocellular carcinoma via PTEN", J Mol Med, 97, pp.1535~1545 (2019)
7. Yu FX, "Hippo pathway in organ size control, tissue homeostasis, and cancer", Cell, 163, pp.811~828 (2015)
8. Meyer KD, "Comprehensive analysis of mRNA methylation reveals enrichment in 3’ UTRs and near stop codons", Cell, 149, pp.1635~1646 (2012)
9. Helm M, "Detecting RNA modi-fications in the epitranscriptome : predict and validate", Nat Rev Genet, 18, pp.275~291 (2017)
10. Zhao BS, "Publisher cor-rection: Post-transcriptional gene regulation by mRNA modifications", Nat Rev Mol Cell Biol, 19, pp.808~ (2018)
11. Fu Y, "Gene expression regulation mediated through reversible m(6)A RNA methylation", Nat Rev Genet, 15, pp.293~306 (2014)
12. Boccaletto P, "MODOMICS: a database of RNA modification pathways. 2017 update", Nucleic Acids Res, 46, pp.D303~D307 (2018)
13. Zhang ZJ, "A panoramic view of RNA modifications : exploring new frontiers", Genome Biol, 19, pp.11~ (2018)
14. Shi H, "Where, when, and how : context-dependent functions of RNA methylation writers, readers, and erasers", Mol Cell, 74, pp.640~650 (2019)
15. Zuo XL, "M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular car-cinoma", J Hematol Oncol, 13, pp.5~ (2020)
16. Zheng QL, "Cytoplasmic m(1)A reader YTHDF3 inhibits trophoblast invasion by downregulation of m(1)A-methylated IGF1R", Cell Discov, 6, pp.12~ (2020)
17. Nachtergaele S, "Chemical modifica-tions in the life of an mRNA transcript", Annu Rev Genet, 52, pp.349~372 (2018)
18. Dominissini D, "Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq", Nature, 485, pp.201~206 (2012)
19. Linder B, "Single-nucleotide-reso-lution mapping of m6A and m6Am throughout the transcriptome", Nat Methods, 12, pp.767~772 (2015)
20. Xiao S, "The RNA N(6)-methyladenosine modification landscape of human fetal tissues", Nat Cell Biol, 21, pp.651~661 (2019)
21. Wang P, "Structural basis for cooperative function of Mettl3 and Mettl14 me-thyltransferases", Mol Cell, 63, pp.306~317 (2016)
22. Wen J, "Zc3h13 regulates nuclear RNA m(6)A methylation and mouse embryonic stem cell self-renewal", Mol Cell, 69, pp.1028e1026~1038e1026 (2018)
23. Ping XL, "Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase", Cell Res, 24, pp.177~189 (2014)
24. Patil DP, "m(6)A RNA methylation promotes XIST-mediated transcriptional re-pression", Nature, 537, pp.369~373 (2016)
25. Jia G, "N6-methyladenosine in nuclear RNA is a major substrate of the obesity-asso-ciated FTO", Nat Chem Biol, 7, pp.885~887 (2011)
26. Zheng G, "ALKBH5 is a mammalian RNA demethylase that impacts RNA meta-bolism and mouse fertility", Mol Cell, 49, pp.18~29 (2013)
27. Wei J, "Differential m(6)A, m(6)Am, and m(1)A demethylation mediated by FTO in the cell nucleus and cytoplasm", Mol Cell, 71, pp.973e975~985e975 (2018)
28. Wang Y, "N6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells", Nat Cell Biol, 16, pp.191~198 (2014)
29. Huang H, "Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation", Nat Cell Biol, 20, pp.285~295 (2018)
30. Wang X, "N(6)-me-thyladenosine modulates messenger RNA translation effi-ciency", Cell, 161, pp.1388~1399 (2015)
31. Shi H, "YTHDF3 facilitates translation and decay of N(6)-methyladenosine-modified RNA", Cell Res, 27, pp.315~328 (2017)
32. Liu N, "N(6)-methyladenosine-dependent RNA structural switches regulate RNA-protein interactions", Nature, 518, pp.560~564 (2015)
33. Meyer KD, "5’ UTR m(6)A promotes cap-independent translation", Cell, 163, pp.999~1010 (2015)
34. Choe J, "mRNA circula-rization by METTL3-eIF3h enhances translation and pro-motes oncogenesis", Nature, 561, pp.556~560 (2018)
35. Lin S, "The m(6)A methyltransferase METTL3 promotes transla-tion in human cancer cells", Mol Cell, 62, pp.335~345 (2016)
36. Seung Hun Han, "Diverse molecular functions of m6A mRNA modification in cancer", Experimental and Molecular Medicine, 52, pp.1~12 (2020), 생화학분자생물학회[DOI]
37. Fazi F, "Interplay between N(6)-methyl-adenosine(m(6)A)and non-coding RNAs in cell devel-opment and cancer", Front Cell Dev Biol, 7, pp.116~ (2019)
38. Sun T, "The role of m6A RNA methylation in cancer", Biomed Pharmacother, 112, pp.108613~ (2019)
39. Chen XY, "The role of m(6)A RNA methylation in human cancer", Mol Cancer, 18, pp.103~ (2019)
40. Wang Q, "METTL3-me-diated m(6)A modification of HDGF mRNA promotes gastric cancer progression and has prognostic signifi-cance", Gut, 69, pp.1193~1205 (2020)
41. Li T, "METTL3 facilitates tumor progression via an m(6)A-IGF2BP2-dependent mecha-nism in colorectal carcinoma", Mol Cancer, 18, pp.112~ (2019)
42. Jin H, "N(6)-methyladenosine modification of ITGA6 mRNA promotes the develop-ment and progression of bladder cancer", EBioMedicine, 47, pp.195~207 (2019)
43. Barbieri I, "Promoter-bound METTL3 maintains myeloid leukaemia by m(6)A-dependent translation control", Nature, 552, pp.126~131 (2017)
44. Han J, "METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221", 222 maturation in m6A-dependent manner, 2019, pp.18, 110~
45. Chen XX, "METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhi-bits tumor metastasis in colorectal cancer", Mol Cancer, 19, pp.106~ (2020)
46. Gu CH, "Mettl14inhibits bladder TIC self-renewal and bladder tumorige-nesis through N-6-methyladenosine of Notch1", Mol Cancer, 18, pp.168~ (2019)
47. Yang X, "METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST", Mol Cancer, 19, pp.46~ (2020)
48. Cohn WE, "Nucleoside-5’-phosphates from ribonucleic acid", Nature, 167, pp.483~484 (1951)
49. Schwartz S, "Transcriptome-wide mapping reveals widespread dyna-mic-regulated pseudouridylation of ncRNA and mRNA", Cell, 159, pp.148~162 (2014)
50. Li X, "Chemical pulldown reveals dynamic pseudouridylation of the mammalian transcriptome", Nat Chem Biol, 11, pp.592~597 (2015)
51. Hoang C, "Cocrystal structure of a tRNA Psi55 pseudouridine synthase : nu-cleotide flipping by an RNA-modifying enzyme", Cell, 107, pp.929~939 (2001)
52. De Zoysa MD, "Posttranscriptional RNA Pseudouridylation", Enzymes, 41, pp.151~167 (2017)
53. Duan J, "Structural mechanism of substrate RNA recruitment in H", ACA RNA-guided pseudouridine synthase, 2009, pp.34, 427~439
54. Rintala-Dempsey AC, "Eukaryotic stand-alone pseudouridine synthases-RNA modifying enzymes and emerging regulators of gene expression?", RNA Biol, 14, pp.1185~1196 (2017)
55. Montanaro L, "Dys-kerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer", J Pathol, 210, pp.10~18 (2006)
56. Sieron P, "DKC1 overex-pression associated with prostate cancer progression", Br J Cancer, 101, pp.1410~1416 (2009)
57. Liu B, "Dyskerin overexpression in human hepatocellular carcinoma is associated with advanced clinical stage and poor patient prognosis", PLoS One, 7, pp.e43147~ (2012)
58. Alawi F, "Correlation of dyskerin expression with active proliferation indepen-dent of telomerase", Head Neck, 33, pp.1041~1051 (2011)
59. Stockert JA, "Predictive value of pseudouridine in prostate cancer", Am J Clin Exp Urol, 7, pp.262~272 (2019)
60. Montanaro L, "Novel dyskerin-mediated mechanism of p53 inactivation through defective mRNA translation", Cancer Res, 70, pp.4767~4777 (2010)
61. McMahon M, "A single H", ACA small nucleolar RNA mediates tumor suppres-sion downstream of oncogenic RAS, 2019, pp.8, e48847~
62. RajBhandary UL, "Nucleotide sequence studies on yeast phenylalanine sRNA", Cold Spring Harb Symp Quant Biol, 31, pp.425~434 (1966)
63. Li X, "Base-resolution mapping reveals distinct m(1)A methylome in nuclear-and mitochondrial-encoded transcripts", Mol Cell, 68, pp.993e1009~1005e1009 (2017)
64. Roundtree IA, "Dynamic RNA modifications in gene expression regulation", Cell, 169, pp.1187~1200 (2017)
65. Li X, "Transcriptome-wide mapping reveals reversible and dynamic N(1)-methyl-adenosine methylome", Nat Chem Biol, 12, pp.311~316 (2016)
66. Liu FG, "ALKBH1-mediated tRNA demethylation regulates translation", Cell, 167, pp.816. e16~828. e16 (2016)
67. Macari F, "TRM6", 61connects PKCalpha with translational control through tRNAi(Met)stabilization : impact on tumorigenesis, 2016, pp.35, 1785~1796
68. Dominissini D, "The dynamic N(1)-methyladenosine methylome in eukaryotic messenger RNA", Nature, 530, pp.441~446 (2016)
69. Seo KW, "YTHDF2 Recognition of N-1-methyladenosine(m(1)A)-modified RNA is associated with transcript destabilization", Acs Chemical Biol, 15, pp.132~139 (2020)
70. Chen Z, "Transfer RNA demethylase ALKBH3 promotes cancer progression via induction of tRNA-derived small RNAs", Nucleic Acids Res, 47, pp.2533~2545 (2019)
71. Somme J, "Characterization of two homo-logous 2’-O-methyltransferases showing different speci-ficities for their tRNA substrates", RNA, 20, pp.1257~1271 (2014)
72. Rebane A, "Locations of several novel 2’-O-methylated nucleotides in human 28S rRNA", BMC Mol Biol, 3, pp.1~ (2002)
73. Dai Q, "Nm-seq maps 2’-O-methylation sites in human mRNA with base precision(vol 14, pg 695, 2017)", Nat Methods, 15, pp.226~227 (2017)
74. Dimitrova DG, "RNA 2’-O-methylation(Nm)modification in human diseases", Genes(Basel), 10, pp.117~ (2019)
75. Belanger F, "Characterization of hMTr1, a human Cap1 2’-O-ribose methyltransferase", J Biol Chem, 285, pp.33037~33044 (2010)
76. Werner M, "2’-O-ribose methylation of cap2 in human : function and evolu-tion in a horizontally mobile family", Nucleic Acids Res, 39, pp.4756~4768 (2011)
77. Ching YP, "Identification and characterization of FTSJ2, a novel human nucleolar protein homologous to bacterial ribosomal RNA methyltransferase", Genomics, 79, pp.2~6 (2002)
78. Koh CM, "Alterations in nucleolar structure and gene expression programs in prostatic neoplasia are driven by the MYC oncogene", Am J Pathol, 178, pp.1824~1834 (2011)
79. Su H, "Elevated snoRNA biogenesis is essential in breast cancer", Oncogene, 33, pp.1348~1358 (2014)
80. Marcel V, "p53 acts as a safeguard of translational control by regulating fibrillarin and rRNA methylation in cancer", Cancer Cell, 24, pp.318~330 (2013)
81. Squires JE, "Widespread occurrence of 5-methylcytosine in human coding and non-coding RNA", Nucleic Acids Res, 40, pp.5023~5033 (2012)
82. Yang X, "5-methylcytosine promotes mRNA export-NSUN2 as the methyltransfer-ase and ALYREF as an m(5)C reader", Cell Res, 27, pp.606~625 (2017)
83. Motorin Y, "5-methylcytosine in RNA : detection, enzymatic formation and biological functions", Nucleic Acids Res, 38, pp.1415~1430 (2010)
84. Bohnsack KE, "Eukaryotic 5-methylcytosine(m(5)C)RNA methyltrans-ferases : mechanisms, cellular functions, and links to dis-ease", Genes(Basel), 10, pp.102~ (2019)
85. Frye M, "The RNA methyltransferase Misu(NSun2)mediates Myc-induced proliferation and is upregulated in tumors", Current Biol, 16, pp.971~981 (2006)
86. Goll MG, "Methy-lation of tRNAAsp by the DNA methyltransferase homo-log Dnmt2", Science, 311, pp.395~398 (2006)
87. Tuorto F, "RNA cytosine methylation by Dnmt2 and NSun2 promotes tRNA stability and protein synthesis", Nat Struct Mol Biol, 19, pp.900~905 (2012)
88. Trixl L, "The dynamic RNA modifi-cation 5-methylcytosine and its emerging role as an epitranscriptomic mark", Wiley Interdiscip Rev RNA, 10, pp.e1510~ (2019)
89. Chen X, "5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs", Nat Cell Biol, 21, pp.978~990 (2019)
90. Xue S, "Depletion of TRDMT1affects 5-methylcytosine modification of mRNA and inhi-bits HEK293 cell proliferation and migration", Biochem Biophys Res Commun, 520, pp.60~66 (2019)
91. Ramanathan A, "mRNA capping : biological functions and applications", Nucleic Acids Res, 44, pp.7511~7526 (2016)
92. Tomikawa C, "7-methylguanosine modifications in transfer RNA(tRNA)", Int J Mol Sci, 19, pp.4080~ (2018)
93. Pandolfini L, "METTL1promotes let-7 microRNA processing via m7G methylation", Mol Cell, 74, pp.1278e1279~1290e1279 (2019)
94. Zhang LS, "Transcriptome-wide mapping of internal N-7-methylguanosine methylome in mammalian mRNA", Mol Cell, 74, pp.1304.e8~1316.e8 (2019)
95. Malbec L, "Dynamic methylome of internal mRNA N-7-methylguanosine and its regulatory role in translation", Cell Res, 29, pp.927~941 (2019)
96. Alexandrov A, "Two proteins that form a complex are required for 7-methylguanosine modification of yeast tRNA", RNA, 8, pp.1253~1266 (2002)
97. Liu Y, "Methyltransferase-like 1(METTL1)served as a tumor sup-pressor in colon cancer by activating 7-methyguanosine(m7G)regulated let-7e miRNA", HMGA2 axis, 2020, pp.249, 117480~
98. Uddin MB, "Dysregulations of functional RNA modifications in cancer, cancer stem-ness and cancer therapeutics", Theranostics, 10, pp.3164~3189 (2020)
99. Niu Y, "N(6)-methyladenosine modification : a novel pharmacologi-cal target for anti-cancer drug development", Acta Pharm Sin B, 8, pp.833~843 (2018)
100. Wilson C, "Pro-grammable m(6)A modification of cellular RNAs with a Cas13-directed methyltransferase", Nat Biotechnol, 38, pp.1431~1440 (2020)

관련 논문AI추천